At 1pm ET on February 2, 2016, the C Diff Foundation will feature XBiotech in its weekly broadcast, “C. diff. Spores and More™”. The company will provide an overview of its True Human™ technology and discuss how it is currently being leveraged in its program to develop a first-in-class oral monoclonal antibody against C. difficile infection.
XBiotech Speakers Include: